CAS
NVO

Cascadia Advisory Services’s Novo Nordisk NVO Stock Holding History

Cascadia Advisory Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$2.57M Sell
53,462
-13,236
-20% -$640K 0.52% 75
2021
Q2 		$2.79M Buy
66,698
+7,064
+12% +$274K 0.6% 49
2021
Q1 		$2.01M Buy
+59,634
New +$2.12M 0.45% 78
2020
Q3 		$1.59M Buy
+45,874
New +$1.53M 0.45% 63

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cascadia Advisory Services's NVO Position: Q3 2021 in Review

Cascadia Advisory Services reduced its Novo Nordisk (NVO) stake by 20% in Q3 2021, selling an estimated $640K and leaving 53,462 shares worth $2.57M. The position accounts for 0.52% of the portfolio, ranked #75.

Cascadia Advisory Services first reported a position in NVO in Q3 2020 and has held it in 4 quarters since. The position peaked at $2.79M in Q2 2021. 805 funds tracked by Wall St. Rank hold NVO as of Q3 2021.

  • Cascadia Advisory Services held 53,462 shares of Novo Nordisk worth $2.57M as of Q3 2021.
  • Cascadia Advisory Services sold 13,236 Novo Nordisk shares in Q3 2021, an estimated $640K.
  • Novo Nordisk made up 0.52% of Cascadia Advisory Services's portfolio in Q3 2021, its #75 holding.
  • Cascadia Advisory Services first reported a position in Novo Nordisk in Q3 2020 and has held it in 4 quarters since.
  • Cascadia Advisory Services's Novo Nordisk position peaked at $2.79M in Q2 2021.
  • 805 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2021.

Based on Cascadia Advisory Services's 13F filing for Q3 2021, filed 12 Nov 2021.